Ovid Therapeutics (OVID) Tax Rate (2021 - 2022)
Ovid Therapeutics (OVID) posted Tax Rate of 0.31% for Q1 2022, down 123.46% on a QoQ basis from 1.33% in Q4 2021, and down 59.0% year-over-year from 0.76% in Q1 2021.
Ovid Therapeutics (OVID) Tax Rate (2021 - 2022) Analysis & Trends
Ovid Therapeutics' Tax Rate history runs 2 years deep, the most recent figure standing at 0.31% for Q1 2022.
- Quarterly Tax Rate fell 59.0% year-over-year to 0.31% in Q1 2022, while the trailing twelve-month figure through Dec 2022 was 0.09% (down 116.0% YoY) and the FY2021 annual result came in at 1.07%, changed N/A from the prior year.
- Tax Rate was 0.31% for Q1 2022 at Ovid Therapeutics, down from 1.33% in the prior quarter.
- Across five years, Tax Rate topped out at 2.52% in Q3 2021 and bottomed at 10.29% in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | 5.61% |
| 4 | BeOne Medicines | 468.98 Bn | 464.19 Bn | 1.35 Bn | 12.29% |
| 5 | Vertex Pharmaceuticals | 123.24 Bn | 115.99 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 70.45 Bn | 61.70 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 63.04 Bn | 63.04 Bn | - | - |
| 8 | Argenx Se | 55.79 Bn | 50.60 Bn | 1.41 Bn | 33.09% |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn | 7.07% |
| 10 | Ovid Therapeutics | 121.66 Mn | -33.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -0.31% |
| Mar 31, 2022 | -0.31% |
| Mar 31, 2022 | -0.31% |
| Dec 31, 2021 | 1.33% |
| Dec 31, 2021 | 1.33% |
| Dec 31, 2021 | 1.33% |
| Sep 30, 2021 | 2.52% |
| Sep 30, 2021 | 2.52% |
| Sep 30, 2021 | 2.52% |
| Jun 30, 2021 | -10.29% |
| Jun 30, 2021 | -10.29% |
| Jun 30, 2021 | -10.29% |
| Mar 31, 2021 | 0.28% |
| Mar 31, 2021 | 0.28% |
| Mar 31, 2021 | 0.28% |